A Survey of Synthetic Cannabinoid Consumption by Current Cannabis Users

REFERENCES

• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). EMCDDA 2009 Thematic Paper—Understanding the ‘Spice’ Phenomenon. Luxembourg: Office for Official Publications of the European Communities; 2009. Available at: http://www.emcdda.europa.eu/attachements.cfm/att_80086_EN_EMCDDA_Understanding%20-the%20’Spice’%20phenomenon_4Update%2020090813.pdf. Acces-sed July 28, 2013.
   Google Scholar
• American Association of Poison Control Centers (AAPCC). Facts about “synthetic marijuana.” . Available at: https://aapcc.s3.amazonaws.com/pdfs/topics/Synthetic_Marijuana_6.2012.pdf. Accessed July 28, 2013.
   Google Scholar
• US Drug Enforcement Agency. Chemicals Used in “Spice” and “K2” Type Products Now Under Federal Control and Regulation. News Release Number: 202-307-7977, March 1, 2011. . Available at: http://www.justice.gov/dea/pubs/pressrel/pr030111.html. Accessed July 28, 2013
   Google Scholar
• Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future National Results on Drug Use: 2012 Overview, Key Findings on Adolescent Drug Use. Ann Arbor: Institute for Social Research, The University of Michigan; 2013. . Available at: www.monitoringthefuture.org/pubs/monographs/mtf-overview2012.pdf. Accessed August 23, 2013
   Google Scholar
• US Department of Justice, Drug Enforcement Administration. Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cannabinoids Into Schedule I. May 16, 2013. 21 CFR Part 1308 [Docket No. DEA-373]. . Available at: http://www.deadiversion.usdoj.gov/fed_regs/rules/2013/fr0516.htm. Accessed July 28, 2013.
   Google Scholar
• United Nations Office on Drugs and Crime (UNODC). World Drug Report 2013. New York: United Nations; 2013. . United Nations Publication, Sales No. E.13.XI.6. . Available at: http://www.unodc.org/unodc/secured/wdr/wdr2013/World_Drug_Report_2013.pdf. Accessed July 28, 2013.
   Google Scholar
• Auwarter V. Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom. 2009;44:832–837.
   PubMed Web of Science ®Google Scholar
• Psychonaut Web Mapping Research Group. Spice Report. London: Institute of Psychiatry, King's College London; 2009. . Available at: www.psychonautproject.eu/documents/reports/Spice.pdf. Accessed July 28, 2013.
   Google Scholar
• Vandrey R, Dunn KE, Fry JA, Girling ER. A survey study to characterize use of Spice products (synthetic cannabinoids). Drug Alcohol Depend. 2012;120:238–241.
   PubMed Web of Science ®Google Scholar
• Gunderson EW, Haughey HM, Ait-Daoud N, Joshi AS, Hart CL. “Spice” and “K2” herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. Am J Addict. 2012;21:320–326.
   PubMed Web of Science ®Google Scholar
• Pertwee 2009 Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. Br J Pharmacol. 2007;153:199–155.
   PubMed Web of Science ®Google Scholar
• Uchiyama N, Kikura-Hanajiri R, Ogata J, et al. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci Int. 2010;198:31–38.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The DAWN Report: Drug-Related Emergency Department Visits Involving Synthetic Cannabinoids. Rockville, MD; . December 4, 2012. . Available at: http://www.samhsa.gov/data/2k12/DAWN105/SR105-synthetic-marijuana.htm. Accessed July 28, 2013.
   Google Scholar
• Centers for Disease Control and Prevention. Acute kidney injury associated with synthetic cannabinoid use—multiple states, 2012. MMWR Morb Mort Wkly Rep. 2013;62:94–98.
   Web of Science ®Google Scholar
• Tofighi B, Lee JD. Internet highs—seizures after consumption of synthetic cannabinoids purchased online. J Addict Med. 2012;6:240–241.
   PubMed Web of Science ®Google Scholar
• Hermanns-Clausen M, Kneisel S, Szabo B, Auwärter V. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction. 2013;108:534–544.
   PubMed Web of Science ®Google Scholar
• Haney M. The marijuana withdrawal syndrome: diagnosis and treatment. Curr Psychiatry Rep. 2005;7:360–366.
   PubMedGoogle Scholar
• Budney AJ, Vandrey RG, Hughes JR, Thostenson JD, Bursac Z. Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. J Subst Abuse Treat. 2008;35:362–368.
   PubMed Web of Science ®Google Scholar
• US Department of Justice, National Drug Intelligence Center. Drug Alert Watch: Use of Synthetic Cannabinoid Products by Teens and Young Adults Increasing. EWS Report 000006. May 18, 2010. . Available at: http://www.justice.gov/archive/ndic/pubs41/41193/sw0006p.pdf. Accessed July 28, 2011.
   Google Scholar
• Scalzo 2010 Scalzo A. Epi-X The Epidemic Information Exchange. K2 Synthetic Marijuana Use Among Teenagers—Missouri, 2010. . Available at: http://www.iowa.gov/odcp/docs/Spice/K2Marijuana.pdf. Accessed August 23, 2013.
   Google Scholar
• Vearrier D, Osterhoudt KC. A teenager with agitation: higher than she should have climbed. Pediatr Emerg Care. 2010;26:462–465.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (text revision) (DSM-IV-TR). Washington, DC: APA; July 2000.
   Google Scholar
• Martin G, Copeland J, Gates P, Gilmour S. The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut off. Drug Alcohol Depend. 2006;83:90–93.
   PubMed Web of Science ®Google Scholar
• Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. Primary care validation of a single-question alcohol screening test. J Gen Intern Med. 2009;24:783–788.
   PubMed Web of Science ®Google Scholar
• National Institute on Alcohol Abuse and Alcoholism (NIAAA). The Physician's Guide to Helping Patients With Alcohol Problems. Bethesda, MD: National Institute of Health; 2005.
   Google Scholar
• Terry-McElrath YM, O’Malley PM, Johnston LD. Middle and high school drug testing and student illicit drug use: a national study 1998–2011. J Adolesc Health. 2013;52:707–715.
   PubMed Web of Science ®Google Scholar
• Zimmermann US, Winkelmann PR, Pilhatsch M, et al. Withdrawal Phenomena and dependence syndrome after the consumption of “Spice Gold.” Dtsch Arztebl Int. 2009;106:464–467.
   PubMed Web of Science ®Google Scholar
• Müller H, Sperling W, Köhrmann M, Huttner HB, Kornbuber J, Maler JM. The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophr Res. 2010;108:309–310.
   Web of Science ®Google Scholar
• Every-Palmer S. Synthetic cannabinoid JWH-018 and psychosis: an explorative study. Drug Alcohol Depend. 2011;117:152–157.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379:55–70.
   PubMed Web of Science ®Google Scholar